Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study

被引：0
|
作者：
Masatomo Ogata
Hirofumi Sumi
Kazuhiro Shiizaki
Naoto Tominaga
机构：
[1] Kawasaki Municipal Tama Hospital,Division of Nephrology and Hypertension
[2] St. Marianna University School of Medicine,Division of Nephrology and Hypertension, Department of Internal Medicine
[3] Nephrology and Dialysis Center Koga,undefined
来源：
Calcified Tissue International | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：254 / 255
页数：1
相关论文
共 50 条
  • [1] Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
    Ogata, Masatomo
    Sumi, Hirofumi
    Shiizaki, Kazuhiro
    Tominaga, Naoto
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2023, 113 (02) : 254 - 255
  • [2] One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
    Tomohiro Saito
    Masahide Mizobuchi
    Tadashi Kato
    Taihei Suzuki
    Yasuro Fujiwara
    Naoaki Kanamori
    Mikio Makuuchi
    Hirokazu Honda
    [J]. Calcified Tissue International, 2023, 112 : 34 - 44
  • [3] One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
    Saito, Tomohiro
    Mizobuchi, Masahide
    Kato, Tadashi
    Suzuki, Taihei
    Fujiwara, Yasuro
    Kanamori, Naoaki
    Makuuchi, Mikio
    Honda, Hirokazu
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2023, 112 (01) : 34 - 44
  • [4] One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
    Pazianas, Michael
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2023, 112 (05) : 628 - 629
  • [5] RE: One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
    Michael Pazianas
    [J]. Calcified Tissue International, 2023, 112 : 628 - 629
  • [6] Therapy With Romosozumab Followed by 1 Year of Denosumab in Hemodialysis Patients With Osteoporosis: An Observational Study
    Saito, Tomohiro
    Mizobuchi, Masahide
    Kato, Tadashi
    Suzuki, Taihei
    Fujiwara, Yasuro
    Kanamori, Naoaki
    Makuuchi, Mikio
    Honda, Hirokazu
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 652 - 653
  • [7] Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
    Tominaga, A.
    Wada, K.
    Okazaki, K.
    Nishi, H.
    Terayama, Y.
    Kato, Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (10) : 1999 - 2009
  • [8] Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
    A. Tominaga
    K. Wada
    K. Okazaki
    H. Nishi
    Y. Terayama
    Y. Kato
    [J]. Osteoporosis International, 2021, 32 : 1999 - 2009
  • [9] Correction: Efficacy of Denosumab in the Treatment of Postmenopausal Osteoporosis: One-year Follow-up, Single Center Study
    Tuncekin, Ismail
    Ilter, Server
    [J]. TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2023, 29 (03): : 184 - 185
  • [10] Renal denervation in the treatment of resistant hypertension: results of a one-year observational study
    Sulimov, V. A.
    Rodionov, A. V.
    Svetankova, A. A.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (03) : 304 - 308
12345